Bhowmik, D. et al. 2025. Integrated Bioinformatics Reveals PLK1 as a Driver and Rapamycin as a Drug Candidate in Stage III–IV Prostate Cancer. Asian Pacific Journal of Cancer Biology. 10, 4 (Nov. 2025), 927–937.